MAPCs at Work Post-Injury (IMAGE)
Caption
Biodistribution analysis shows how MAPCs (gold) home to the spleen, a primary reservoir for inflammatory cells in the body. The MAPCs were intravenously administered approximately one day after the spinal cord injury.
Credit
<i>Scientific Reports</i>: Adapted from Figure 6-D in "Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury"
Usage Restrictions
None
License
Licensed content